Lifestyle changes cut diabetes risk in high-risk patients

October 16, 2013
Lifestyle changes cut diabetes risk in high-risk patients
Comprehensive lifestyle interventions decrease the incidence of type 2 diabetes in high-risk patients, but the benefits are less clear in diagnosed patients, according to a review published in the Oct. 15 issue of the Annals of Internal Medicine.

(HealthDay)—Comprehensive lifestyle interventions decrease the incidence of type 2 diabetes in high-risk patients, but the benefits are less clear in diagnosed patients, according to a review published in the Oct. 15 issue of the Annals of Internal Medicine.

Elizabeth Sumamo Schellenberg, M.P.H., from the University of Alberta in Edmonton, Canada, and colleagues reviewed the literature and conducted a meta-analysis of nine randomized, controlled trials with patients at risk for and 11 including patients with diabetes to examine the effectiveness of lifestyle interventions. In all trials, lifestyle interventions (at least three months duration) such as exercise, diet, and at least one other component were compared with standard care.

The researchers found that based on seven studies, the risk of diabetes was decreased with lifestyle interventions, from the end of the intervention to up to 10 years after the intervention. Two trials (which included pharmacotherapy) involving patients with diabetes reported no improvement in all-cause mortality. Pooling of composite outcomes for cardiovascular disease was hindered by heterogeneity. At 13 years' follow-up one trial reported improvement in microvascular outcomes.

"Comprehensive lifestyle interventions effectively decrease the incidence of type 2 diabetes in high-risk patients," the authors write. "In who have already been diagnosed with type 2 diabetes, the evidence of benefit of comprehensive on patient-oriented outcomes is less clear."

Explore further: Diabetes care for African-Americans can be improved

More information: Full Text

Related Stories

Diabetes care for African-Americans can be improved

April 1, 2013

(HealthDay)—For African-Americans with type 2 diabetes, health care-promoted interventions targeting patients, the health care system, or both, can improve the quality of care, according to a review and meta-analysis published ...

Metformin may increase risk of cognitive impairment

September 21, 2013

(HealthDay)—Metformin may increase the risk of cognitive impairment in patients with diabetes; however, calcium supplementation may attenuate this risk, according to research published online Sept. 5 in Diabetes Care.

Recommended for you

New study reveals a novel protein linked to type 2 diabetes

August 16, 2016

Findings from Boston University School of Medicine (BUSM), which appear in eLife, provide a possible explanation as to why most people who are obese develop insulin resistance and type 2 diabetes. A minority of obese individuals, ...

Gene variant explains differences in diabetes drug response

August 9, 2016

The first results from a large international study of patients taking metformin, the world's most commonly used type 2 diabetes drug, reveal genetic differences among patients that may explain why some respond much better ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.